Acer Medical Inc. (TPEX:6857)

Acer Medical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-27.36	-38.18	-54.71
Depreciation & Amortization	0.57	0.72	0.48
Other Amortization	0.66	0.59	0.19
Loss (Gain) From Sale of Assets	-	0	-
Stock-Based Compensation	0.03	-	0.02
Other Operating Activities	-2.95	-0.53	-0.06
Change in Accounts Receivable	6.17	-4.5	-0.47
Change in Inventory	10.91	-12.13	0.76
Change in Accounts Payable	-11.26	7.56	0.06
Change in Unearned Revenue	0.23	0.01	-1.02
Change in Other Net Operating Assets	2.31	-6.68	8.97
Operating Cash Flow	-20.7	-53.13	-45.77
Capital Expenditures	-	-	-3.2
Sale of Property, Plant & Equipment	-	0.01	0.04
Cash Acquisitions	3.61	-	-
Sale (Purchase) of Intangibles	-	-0.76	-4.21
Investment in Securities	-	-2.5	80
Other Investing Activities	-0.16	-0.15	-
Investing Cash Flow	3.45	-3.4	72.63
Issuance of Common Stock	-	-	200.01
Financing Cash Flow	-	-	200.01
Net Cash Flow	-17.25	-56.53	226.88
Free Cash Flow	-20.7	-53.13	-48.97
Free Cash Flow Margin	-41.27%	-193.57%	-374.94%
Free Cash Flow Per Share	-1.36	-3.49	-3.97
Cash Income Tax Paid	0.34	0.23	0.01
Levered Free Cash Flow	-11.08	-41.44	-
Unlevered Free Cash Flow	-11.08	-41.44	-
Change in Net Working Capital	-6.53	16.26	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.